157 related articles for article (PubMed ID: 11163092)
1. Soluble HLA class I/CD8 ligation triggers apoptosis in EBV-specific CD8+ cytotoxic T lymphocytes by Fas/Fas-ligand interaction.
Contini P; Ghio M; Merlo A; Brenci S; Filaci G; Indiveri F; Puppo F
Hum Immunol; 2000 Dec; 61(12):1347-51. PubMed ID: 11163092
[TBL] [Abstract][Full Text] [Related]
2. Soluble HLA class I molecules/CD8 ligation trigger apoptosis of CD8+ cells by Fas/Fas-ligand interaction.
Puppo F; Contini P; Ghio M; Indiveri F
ScientificWorldJournal; 2002 Feb; 2():421-3. PubMed ID: 12806026
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis of antigen-specific T lymphocytes upon the engagement of CD8 by soluble HLA class I molecules is Fas ligand/Fas mediated: evidence for the involvement of p56lck, calcium calmodulin kinase II, and Calcium-independent protein kinase C signaling pathways and for NF-kappaB and NF-AT nuclear translocation.
Contini P; Ghio M; Merlo A; Poggi A; Indiveri F; Puppo F
J Immunol; 2005 Dec; 175(11):7244-54. PubMed ID: 16301629
[TBL] [Abstract][Full Text] [Related]
4. Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8.
Fournel S; Aguerre-Girr M; Huc X; Lenfant F; Alam A; Toubert A; Bensussan A; Le Bouteiller P
J Immunol; 2000 Jun; 164(12):6100-4. PubMed ID: 10843658
[TBL] [Abstract][Full Text] [Related]
5. Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation.
Contini P; Ghio M; Poggi A; Filaci G; Indiveri F; Ferrone S; Puppo F
Eur J Immunol; 2003 Jan; 33(1):125-34. PubMed ID: 12594841
[TBL] [Abstract][Full Text] [Related]
6. Soluble human MHC class I molecules induce soluble Fas ligand secretion and trigger apoptosis in activated CD8(+) Fas (CD95)(+) T lymphocytes.
Puppo F; Contini P; Ghio M; Brenci S; Scudeletti M; Filaci G; Ferrone S; Indiveri F
Int Immunol; 2000 Feb; 12(2):195-203. PubMed ID: 10653855
[TBL] [Abstract][Full Text] [Related]
7. Soluble HLA class I molecules induce natural killer cell apoptosis through the engagement of CD8: evidence for a negative regulation exerted by members of the inhibitory receptor superfamily.
Spaggiari GM; Contini P; Carosio R; Arvigo M; Ghio M; Oddone D; Dondero A; Zocchi MR; Puppo F; Indiveri F; Poggi A
Blood; 2002 Mar; 99(5):1706-14. PubMed ID: 11861287
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Epstein-Barr virus (EBV)-specific CD8+ cytotoxic T lymphocyte (CTL) activity by soluble HLA class I in vitro.
Gansuvd B; Hagihara M; Munkhbat B; Kanai N; Morita N; Munkhtuvshin N; Chargui J; Kato S; Hotta T; Tsuji K
Clin Exp Immunol; 2000 Jan; 119(1):107-14. PubMed ID: 10606971
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the Fas ligand/Fas-dependent apoptosis of antiretroviral, class I MHC tetramer-defined, CD8+ CTL by in vivo retrovirus-infected cells.
Rich RF; Green WR
J Immunol; 2002 Mar; 168(6):2751-8. PubMed ID: 11884442
[TBL] [Abstract][Full Text] [Related]
10. Immunosensitization of melanoma tumor cells to non-MHC Fas-mediated killing by MART-1-specific CTL cultures.
Frost PJ; Butterfield LH; Dissette VB; Economou JS; Bonavida B
J Immunol; 2001 Mar; 166(5):3564-73. PubMed ID: 11207317
[TBL] [Abstract][Full Text] [Related]
11. Porcine endothelial cells, unlike human endothelial cells, can be killed by human CTL via Fas ligand and cannot be protected by Bcl-2.
Zheng L; Ben LH; Pober JS; Bothwell AL
J Immunol; 2002 Dec; 169(12):6850-5. PubMed ID: 12471117
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory effects of blood transfusions: the synergic role of soluble HLA Class I free heavy-chain molecules detectable in blood components.
Ghio M; Contini P; Ubezio G; Mazzei C; Puppo F; Indiveri F
Transfusion; 2008 Aug; 48(8):1591-7. PubMed ID: 18466172
[TBL] [Abstract][Full Text] [Related]
13. Soluble HLA class I induces NK cell apoptosis upon the engagement of killer-activating HLA class I receptors through FasL-Fas interaction.
Spaggiari GM; Contini P; Dondero A; Carosio R; Puppo F; Indiveri F; Zocchi MR; Poggi A
Blood; 2002 Dec; 100(12):4098-107. PubMed ID: 12393468
[TBL] [Abstract][Full Text] [Related]
14. Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T lymphocytes.
Zavazava N; Krönke M
Nat Med; 1996 Sep; 2(9):1005-10. PubMed ID: 8782458
[TBL] [Abstract][Full Text] [Related]
15. Tolerance induction by veto CTLs in the TCR transgenic 2C mouse model. II. Deletion of effector cells by Fas-Fas ligand apoptosis.
Reich-Zeliger S; Gan J; Bachar-Lustig E; Reisner Y
J Immunol; 2004 Dec; 173(11):6660-6. PubMed ID: 15557157
[TBL] [Abstract][Full Text] [Related]
16. Differential role of Fas/Fas ligand interactions in cytolysis of primary and metastatic colon carcinoma cell lines by human antigen-specific CD8+ CTL.
Bergmann-Leitner ES; Abrams SI
J Immunol; 2000 May; 164(9):4941-54. PubMed ID: 10779805
[TBL] [Abstract][Full Text] [Related]
17. CD4+ T cell-induced differentiation of EBV-transformed lymphoblastoid cells is associated with diminished recognition by EBV-specific CD8+ cytotoxic T cells.
Khanolkar A; Fu Z; Underwood LJ; Bondurant KL; Rochford R; Cannon MJ
J Immunol; 2003 Mar; 170(6):3187-94. PubMed ID: 12626577
[TBL] [Abstract][Full Text] [Related]
18. Counter-regulation of cytolytic activity and cytokine production in HIV-1-specific murine CD8+ cytotoxic T lymphocytes by free antigenic peptide.
Takahashi M; Nakagawa Y; Berzofsky JA; Takahashi H
Int Immunol; 2001 Jan; 13(1):43-51. PubMed ID: 11133833
[TBL] [Abstract][Full Text] [Related]
19. Disparate cytotoxic activity of nickel-specific CD8+ and CD4+ T cell subsets against keratinocytes.
Traidl C; Sebastiani S; Albanesi C; Merk HF; Puddu P; Girolomoni G; Cavani A
J Immunol; 2000 Sep; 165(6):3058-64. PubMed ID: 10975816
[TBL] [Abstract][Full Text] [Related]
20. Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin.
Seki N; Brooks AD; Carter CR; Back TC; Parsoneault EM; Smyth MJ; Wiltrout RH; Sayers TJ
J Immunol; 2002 Apr; 168(7):3484-92. PubMed ID: 11907109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
